Volume : 09, Issue : 03, March – 2021

25.THE RP-UPLC METHOD FOR SIMULTANEOUS QUANTIFICATION OF LESINURAD AND ALLOPURINOL

GV Subrahmanyam, JVLN Seshagiri Rao, AKM Pawar

 

Abstract :

In order to develop a newer or improved analytical method, the analyst has to set some goals. The method should be precise to the drug under study. It is necessary to determine the analyte at trace levels accurately. The UPLC techniques have now become extremely reliable and indispensable. Lesinurad is an oral uric acid transporter 1 (URAT1) inhibitor indicated for the treatment of hyperuricemia associated with gout. Allopurinol is a xanthine oxidase enzyme inhibitor that is considered to be one of the most effective drugs used to decrease urate levels and is frequently used in the treatment of chronic gout. Run time was selected to be 2 min because the analysis gave peaks around 0.401 and 0.718 ±0.02 min of Lesinurad and Allopurionol. The percent recovery was found to be in between 98.0 to 102.0%. The analytical method was found to be linear over the range 50-300 µg/mL of Lesinurad and Allopurionol of the target concentration.
Keywords: RP-UPLC, Lesinurad, Allopurionol, Precision, Accuracy

Cite This Article:

Please cite this article in press GV Subrahmanyam et al., The RP-UPLC Method For Simultaneous Quantification Of Lesinurad And Allopurinol., Indo Am. J. P. Sci, 2021; 08(03).

Number of Downloads : 10

References:

1. ICH, Validation of analytical procedures: Text and Methodology. International Conference on Harmonization, IFPMA , Geneva , (1996)
2. https://www.drugbank.ca/drugs/DB11560
3. https://www.drugbank.ca/drugs/DB00437
4. https://www.accessdata.fda.gov/drugsatfda_docs/nda/2017/209203Orig1s000MultidisciplineR.pdf
5. D Dastiagiriamma, C.Kistayya, H.M.Sowjanya, K. Hemalatha, Simultaneous Estimation of Lesinurad And Allopurinol by using Reverse Phase High Performance Liquid Chromatography In API And Marketed Formulation. Innovat International Journal Of Medical & Pharmaceutical Sciences, 2018, 3(1), 9-12.
6. B. Rama Rao, V.Venkata Rao, B.S. Venkateswarlu, Development and Validation of Reversed-Phase HPLC Isocratic Method for the Simultaneous Estimation of Lesinurad and Allopurinol, .J Pharm Res, 2018,7(11), 257-260.
7. Xiao-Yang ZhouLing-Jing YuanZhe ChenPeng-Fei TangXiang-Yu LiGuo-Xin HuJian-Ping Cai, Determination of lesinurad in rat plasma by a UHPLC–MS/MS assay, Chemistry Central Journal, 2017, 11(1), 353-356.
8. Attia KAM, El-Abasawi NM, A.El-Olemy, AH.Abdelazim, Validated Stability Indicating High Performance Liquid Chromatographic Determination of Lesinurad, J Chromatogr Sci. 2018 Apr 1,56(4), 358-366.
9. MKI Reinders, LC Nijdam, ENvan Roon, KLMovig, TL Jasen , MA van de Laar, JR Brouwers, A simple method for quantification of allopurinol and oxipurinol in human serum by high-performance liquid chromatography with UV-detection, J Pharm Biomed Anal, 2007 Oct 18, 45(2), 312-317.
10. S.Revathi, A Gopi Reddy, K.Narendra Naidu, Dr.V.Kiran kumar,. Development and validation of RP-HPLC method for simultaneousestimation of allopurinol and alphalipoicacid in bulk and tablet dosage form., IJPAR , 2016,5(4), 602-612.